Literature DB >> 19786539

CD8+ cell depletion of SHIV89.6P-infected macaques induces CD4+ T cell proliferation that contributes to increased viral loads.

Yvonne M Mueller1, Duc H Do, Jean D Boyer, Muhamuda Kader, Joseph J Mattapallil, Mark G Lewis, David B Weiner, Peter D Katsikis.   

Abstract

Previous studies have shown that depletion of CD8(+) cells during acute and chronic simian immunodeficiency virus (SIV) infection leads to increased viral replication, morbidity, and mortality, which have been attributed to loss of CD8(+) T cell-mediated control of SIV. However, these studies did not exclude that CD8(+) cell depletion increased homeostatic proliferation of CD4(+) T cells, resulting in increased viral targets and, therefore, viral rebound. Chronically SHIV89.6P-infected cynomolgus macaques were CD8(+) cell-depleted, and the frequency, cell number, and phenotype of CD4(+) T cells and viral infection were examined using flow cytometry and quantitative real-time PCR. The frequency and number of Ki-67-expressing CD4(+) T cells were increased with CD8(+) cell depletion. This proliferation of CD4(+) T cells occurred even in animals with no rebound of viral loads. Most of the proliferating cells were effector memory CD4(+) T cells. Plasma simian HIV (SHIV) RNA copies positively correlated with proliferating CD4(+) T cells and SHIV DNA copies in Ki-67(+) CD4(+) T cells. Although this study does not exclude an important role for virus-specific CD8(+) T cells in SIV and SHIV infection, our data suggest that homeostatic proliferation is an important contributor to increases in plasma viremia that follow CD8(+) cell depletion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786539      PMCID: PMC2757467          DOI: 10.4049/jimmunol.0900141

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody.

Authors:  J E Schmitz; M A Simon; M J Kuroda; M A Lifton; M W Ollert; C W Vogel; P Racz; K Tenner-Racz; B J Scallon; M Dalesandro; J Ghrayeb; E P Rieber; V G Sasseville; K A Reimann
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection.

Authors:  C Lapenta; M Boirivant; M Marini; S M Santini; M Logozzi; M Viora; F Belardelli; S Fais
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

4.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

5.  Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa.

Authors:  G Meng; M T Sellers; M Mosteller-Barnum; T S Rogers; G M Shaw; P D Smith
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

6.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

Authors:  R S Veazey; M DeMaria; L V Chalifoux; D E Shvetz; D R Pauley; H L Knight; M Rosenzweig; R P Johnson; R C Desrosiers; A A Lackner
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

7.  Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.

Authors:  Y Zhang; B Lou; R B Lal; A Gettie; P A Marx; J P Moore
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.

Authors:  J D Lifson; J L Rossio; M Piatak; T Parks; L Li; R Kiser; V Coalter; B Fisher; B M Flynn; S Czajak; V M Hirsch; K A Reimann; J E Schmitz; J Ghrayeb; N Bischofberger; M A Nowak; R C Desrosiers; D Wodarz
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy.

Authors:  K Tenner-Racz; H J Stellbrink; J van Lunzen; C Schneider; J P Jacobs; B Raschdorff; G Grosschupff; R M Steinman; P Racz
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  15 in total

1.  IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques.

Authors:  Enrico Lugli; Yvonne M Mueller; Mark G Lewis; Francois Villinger; Peter D Katsikis; Mario Roederer
Journal:  Blood       Date:  2011-07-14       Impact factor: 22.113

Review 2.  HIV therapeutic vaccines: moving towards a functional cure.

Authors:  Geetha H Mylvaganam; Guido Silvestri; Rama Rao Amara
Journal:  Curr Opin Immunol       Date:  2015-05-18       Impact factor: 7.486

3.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.

Authors:  Thorsten Demberg; Amelia C Ettinger; Stanley Aladi; Katherine McKinnon; Thea Kuddo; David Venzon; L Jean Patterson; Terry M Phillips; Marjorie Robert-Guroff
Journal:  Vaccine       Date:  2011-06-25       Impact factor: 3.641

5.  Emergence of simian immunodeficiency virus-specific cytotoxic CD4+ T cells and increased humoral responses correlate with control of rebounding viremia in CD8-depleted macaques infected with Rev-independent live-attenuated simian immunodeficiency virus.

Authors:  Agneta von Gegerfelt; Antonio Valentin; Candido Alicea; Koen K A Van Rompay; Marta L Marthas; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  J Immunol       Date:  2010-08-11       Impact factor: 5.422

6.  Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Ankita Chowdhury; Timothy L Hayes; Steven E Bosinger; Benton O Lawson; Thomas Vanderford; Joern E Schmitz; Mirko Paiardini; Michael Betts; Ann Chahroudi; Jacob D Estes; Guido Silvestri
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

7.  CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus.

Authors:  Matthew S Sutton; Amy Ellis-Connell; Alexis J Balgeman; Gabrielle Barry; Andrea M Weiler; Scott J Hetzel; Yan Zhou; Annie W Lau-Kilby; Rosemarie D Mason; Kristin K Biris; John R Mascola; Nancy J Sullivan; Mario Roederer; Thomas C Friedrich; Shelby L O'Connor
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

8.  HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice.

Authors:  Nicolas Y Petit; Sidonie Lambert-Niclot; Anne-Geneviève Marcelin; Sylvie Garcia; Gilles Marodon
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

9.  Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir.

Authors:  Taina T Immonen; Christine M Fennessey; Leslie Lipkey; Abigail Thorpe; Gregory Q Del Prete; Jeffrey D Lifson; Miles P Davenport; Brandon F Keele
Journal:  PLoS Pathog       Date:  2021-06-18       Impact factor: 6.823

10.  Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes.

Authors:  Dionysios C Watson; Eirini Moysi; Antonio Valentin; Cristina Bergamaschi; Santhi Devasundaram; Sotirios P Fortis; Jenifer Bear; Elena Chertova; Julian Bess; Ray Sowder; David J Venzon; Claire Deleage; Jacob D Estes; Jeffrey D Lifson; Constantinos Petrovas; Barbara K Felber; George N Pavlakis
Journal:  PLoS Pathog       Date:  2018-02-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.